Newsfeeds Archive - Page 2 of 3

1 minute read

News

Mineralys Therapeutics Announced JAMA Publication Of Full Target-HTN Phase 2 Trial Results for Lorundrostat In Uncontrolled and Treatment-Resistant Hypertension

September 10, 10:24 AM

Mineralys Therapeutics, Inc. (NASDAQ:MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic kidney disease and other diseases driven by abnormally elevated

MLYS

12 minute read

Options

Stocks That Hit 52-Week Lows On Wednesday

By Benzinga Insights

September 6, 2:43 PM

On Wednesday, 179 companies reached new 52-week lows.

AAMC

2 minute read

Mineralys Therapeutics Selected For Oral Poster Presentation Of Target-HTN Phase 2 Trial Results At 2023 AHA Hypertension Scientific Sessions

By Happy Mohamed

September 5, 4:09 PM

MLYS

2 minute read

Analyst Ratings

Where Mineralys Therapeutics Stands With Analysts

By Benzinga Insights

May 16, 2:02 PM

Over the past 3 months, 7 analysts have published their opinion on Mineralys Therapeutics (NASDAQ:MLYS) stock. These analysts…

MLYS

11 minute read

Earnings

Earnings Scheduled For May 15, 2023

By Benzinga Insights

May 15, 5:32 AM

Companies Reporting Before The Bell • Caledonia Mining (AMEX:CMCL) is expected to report earnings for its first quarter. • Sohu.com (NASDAQ:SOHU) is projected to report earnings for its first quarter.

AAMC